Janna Muhlhausen

Janna Muhlhausen has over 15 years of experience in financial operations and leadership roles. Janna is currently serving as the Head of Financial Operations at Cerevel Therapeutics, LLC since October 2019. Prior to this, Janna held various positions at Biogen Idec, including Director of Financial Shared Services and Associate Director of Financial Operations. During their time at Biogen Idec, they achieved notable accomplishments such as successfully leading the spin-off of P2P for Biogen's Hemophilia Division and collaborating with HR to implement the Workday platform. Janna also has experience in non-profit work as the President of Toots for Tufts, an organization supporting brain cancer research. Earlier in their career, they worked at Millennium Pharmaceuticals as a Manager. Janna has a strong background in financial operations, process improvement, and project management.

Janna Muhlhausen attended the University of Massachusetts Amherst from 1993 to 1997. Janna did not complete a degree or specialize in a specific field of study during this period. Following their time at the University of Massachusetts Amherst, Janna went on to pursue a Master of Business Administration (MBA) at the Worcester Polytechnic Institute. The duration of their MBA program is not provided.